Skip to main content
Advanced Technical IVT

somatomedin

Pronunciation: so-MAT-oh-mee-din

Growth factors, primarily IGF-1, that mediate the growth-promoting effects of growth hormone.

Full Definition

Somatomedins are a group of growth factors, primarily insulin-like growth factor 1 (IGF-1), that mediate many of the growth-promoting effects of growth hormone (GH). These peptide hormones are produced mainly by the liver in response to GH stimulation and act on various tissues to promote cellular growth and proliferation. The term 'somatomedin' was historically used before the specific identification of IGF-1 and IGF-2. In pediatric endocrinology, measuring somatomedin levels (now typically IGF-1) helps assess growth hormone activity and diagnose growth disorders. The somatomedin hypothesis explains how growth hormone exerts its effects through these intermediary factors rather than acting directly on target tissues.

Usage

Usage note: Historical term; modern usage typically refers to IGF-1 specifically.

In Context

  • "Low somatomedin levels despite adequate growth hormone suggested GH resistance syndrome." — Research case report
  • "The somatomedin hypothesis explains the delayed growth response to growth hormone therapy." — Medical education material

Also known as

IGF-1 insulin-like growth factor

Don't confuse with

growth hormone IGFBP insulin

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON